Market Drivers:

  • Resistance among various microbial species to different antimicrobial drugs have emerged as a serious explanation for public health threat. Consistent with World Health Organization (WHO), these resistant microorganisms like bacteria, fungi, viruses, and parasites are ready to combat attack by antimicrobial drugs, which results in ineffective treatment leading to persistence and spreading of infections.
  • Increasing number of multidrug resistance cases in tuberculosis (TB), malaria, HIV, influenza, et al. among the worldwide population is predicted to end in the increasing adoption of Antimicrobial Susceptibility Testing to scale back the resistance exposure during the forecast period. As an example, consistent with the WHO, in 2016, an estimated 490,000 people worldwide developed MDR-TB. The countries with the most important numbers of MDR/RR-TB cases were China, India and therefore, the Russia.
  • Moreover, development of genotypic-based methods offering rapid and accurate detection or confirmation of antimicrobial resistance is predicted to drive the market growth. As an example, the Accelerate ID/AST System or ID/AST System (Accelerate) aims to scale back the turnaround by using genetic methods.

Statistics:

Global Antimicrobial Susceptibility Testing Market Share (%) Analysis, By Product Type, 2017

Message Me to Request Sample copy

Market Restraints

  • Stringent government regulations is the major restraining factor for the antimicrobial susceptibility testing market growth. Regulatory procedures creates barrier to AST development, as clinical validation and trials are lengthy and sometimes too costly for small-sized or medium-sized enterprises or organizations.
  • For instance, in the U.S., a manufacturer who intends to plug a tool of generic type must conform to the overall controls of Section 513(a)(1)(B) of the Federal Food, Drug and Cosmetic Act, address the risks to health-related to the AST system, and acquire a considerable equivalence assessment from the FDA.

Regional Market Insights

North America is predicted to be the foremost lucrative region within the antimicrobial susceptibility testing market in 2017 thanks to the emergence of a multidrug resistant strain of Salmonella within the U.S. as an example, consistent with the Centers for Disease Control and Prevention (CDC), September 2018, around two million people are infected with antibiotic-resistant bacteria within the U.S. annually and around 23,000 people die as a result.

Message Me to Request PDF Brochure

Moreover, government agencies within the U.S. have taken steps to stop and control antibiotic resistance, which is predicted to extend the adoption of antimicrobial susceptibility testing within the country.
Asia Pacific antimicrobial susceptibility testing market revenue is predicted to foresee significant growth over the forecast period thanks to high prevalence of microbial infections and increasing consumption of antibiotics, eventually developing resistance among the population. Consistent with a WHO report, in 2014, multidrug-resistant tuberculosis rates were high in India and treatment for the disease is usually limited.

Global Antimicrobial Susceptibility Testing market price (US$ Mn) & Y-o-Y Growth (%)

Key Players

Key Players operating within the global Antimicrobial Susceptibility Testing Market include bioMérieux S.A., HiMedia Laboratories, Alifax Holding S.p.A., Creative Diagnostics, Resistell AG, Danaher Corporation, Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Merck KGaA, and Bio-Rad Laboratories, Inc.

  • 210
  • 01/01/2019
  • 4500